Companies: 10,795·Total market cap: $144.5T
Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

MDGLNASDAQHealthcare● Active
$467.28
$-19.70(-4.05%)
Market Cap$10.8B
P/E Ratio—
52W High$615
52W Low$271.96
Overview

Madrigal Pharmaceuticals, Inc. (MDGL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDGL · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$983.6M▲ +6.2% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$198.7M
cashAndCashEquivalents
Short-Term Investments
$784.9M
shortTermInvestments
YoY Change vs Prior Year
+6.2%
vs prior fiscal year
Latest Quarter
$817.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$983.6MCash on Hand
Total Debt$354.4MTotal Debt
Net Cash / Net Debt+$629.2MNet Cash Position
Cash vs Debt Ratio
Cash 74%Debt 26%

Madrigal Pharmaceuticals, Inc. has a net cash position of $629.2M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$983.6M − $354.4M = +$629.2M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MDGL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$983.6M+6.2%
Dec 31, 2024$926.3M+46.1%
Dec 31, 2023$634.1M+76.7%
Dec 31, 2022$358.8M+32.7%
Dec 31, 2021$270.3M-4.9%
MDGL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.YOU
MDGL
$983.6M9.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Madrigal Pharmaceuticals, Inc. (MDGL) cash on hand as of December 31, 2025 is $983.6M, comprising $198.7M in cash and cash equivalents (CCE) plus $784.9M in short-term investments — reported as Madrigal Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Madrigal Pharmaceuticals, Inc. cash reserves or cash position.

Madrigal Pharmaceuticals, Inc. annual cash on hand history shows increased +6.2% in 2025: increased +6.2% in 2025. Madrigal Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Madrigal Pharmaceuticals, Inc. carries total debt of $354.4M against cash of $983.6M, resulting in a net cash position of +$629.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MDGL cash on hand · 5 questions

As of December 31, 2025, Madrigal Pharmaceuticals, Inc. (MDGL) has $983,559,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $198,693,000 in cash and cash equivalents (CCE) plus $784,866,000 in short-term investments. Latest quarter (March 31, 2026): $817,926,000. Data sourced from the annual 10-K filing via FMP.

MDGL cash on handMDGL cash reservesMDGL cash 2025how much cash does MDGL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Madrigal Pharmaceuticals, Inc. · Madrigal Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025